April 9, 2019 / 5:08 AM / 16 days ago

BRIEF-Novartis Aims For Strong Dividend, No Adjustment For Alcon Spin-Off

April 9 (Reuters) - Novartis Ag:

* CONTINUES TRANSFORMATION INTO A LEADING MEDICINES COMPANY WITH COMPLETION OF ALCON SPIN-OFF

* NOVARTIS PLANS TO PAY A STRONG AND GROWING ANNUAL DIVIDEND, FROM CHF 2.85 PER SHARE PAID IN 2019, WITH NO ADJUSTMENT FOR ALCON SPIN-OFF

* SHARE BUYBACK OF UP TO USD 5 BILLION ANNOUNCED IN JUNE 2018 EXPECTED TO BE COMPLETED IN 2019

* SUCCESSFUL EXECUTION OF ALCON SPIN-OFF ALLOWS NOVARTIS TO FULLY FOCUS ITS CAPITAL ALLOCATION AND MANAGEMENT ATTENTION ON MEDICINES

* SHARE BUYBACKS WILL CONTINUE TO BE PART OF MIX TO CREATE SHAREHOLDER VALUE, WITH USD 0.8 BILLION OF AN UP TO USD 5 BILLION COMMITMENT COMPLETED IN 2018 Source text for Eikon: Further company coverage: (Berlin Speed Desk)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below